Chewy (NYSE:CHWY) held its 2026 Annual Meeting of Stockholders, with Chairman of the Board Raymond Svider presiding over the virtual meeting and announcing preliminary voting results on four proposals.
Svider said the meeting was “duly and lawfully convened” after confirming that notice of the meet
Few things are harder than watching savings disappear one trade at a time. Options can deliver eye-popping gains, but they can also wipe out years of hard work in a matter of days when a trade moves the wrong way—or
Astrazeneca (NYSE:AZN) told investors and analysts that it is continuing to embed sustainability into its business strategy while updating some of its 2030 targets to reflect growth and lessons learned from existing programs.
During the company’s 2026 Sustainability Update, Pam Cheng, EVP Global Op
The Oracle of Omaha understands that too many investors easily fall into the trap of trying to outperform the market, ultimately undermining their own performance.
The U.S. added 441,078 new millionaires last year, according to the UBS Global Wealth Report 2026. That works out to more than 1,200 new millionaires every day and is an increase of 1.9% from 2024. The report also
Vertex Pharmaceuticals (NASDAQ:VRTX) said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in cash, a transaction Vertex executives described as a strategic expansion into specialty endocrinology.
On a conference call announcing the deal, Vertex CEO
